You are here

  • Home
  • Archive
  • Volume 10, Issue 10
  • Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity

Article metrics

Article menu

Download PDFPDF

XML
HIV/AIDS
Protocol
Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity

 

Online download statistics by month:

Online download statistics by month: October 2020 to April 2024

AbstractFullPdf
Oct 202021921156
Nov 202011611226
Dec 2020757232
Jan 2021706534
Feb 202163589
Mar 2021787331
Apr 2021615621
May 2021595812
Jun 2021312919
Jul 2021272613
Aug 2021514814
Sep 2021485910
Oct 2021445134
Nov 2021324127
Dec 202129379
Jan 202278838
Feb 202227348
Mar 202226309
Apr 2022475416
May 2022273122
Jun 2022435119
Jul 202241449
Aug 2022525118
Sep 202239378
Oct 2022363510
Nov 2022353012
Dec 202243457
Jan 2023393820
Feb 2023303113
Mar 202332298
Apr 202319186
May 202321173
Jun 202316165
Jul 2023222114
Aug 202327235
Sep 202336365
Oct 202345432
Nov 2023444411
Dec 2023979222
Jan 202442388
Feb 2024272611
Mar 2024171452
Apr 2024111115
Total20222018693